CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +272 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +223 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +223 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +530 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +755 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +298,320 | 477,870 | ||
| 2021-06-10 | ADAMS THOMAS PHD Former Director | Other acquisition · Stock Options | +173,145 | 477,870 | ||
| 2020-06-17 | ADAMS THOMAS PHD Executive Chairman | Grant or award · Stock Options | +173,145 | 477,870 | ||
| 2020-05-14 | ADAMS THOMAS PHD Director | Purchase | +13,986 | $1.43 | $20K | 18,875 |
| 2019-06-20 | ADAMS THOMAS PHD Chief Executive Officer | Grant or award · Stock Options | +298,230 | 304,725 | ||
| 2018-01-23 | ADAMS THOMAS PHD Director | Grant or award · Stock Options | +54,322 | 467,277 | ||
| 2018-01-02 | ADAMS THOMAS PHD Director | Option exercise | +16,667 | 351,959 | ||
| 2018-01-02 | ADAMS THOMAS PHD Director | Option exercise · Restricted Stock Units | −16,667 | 0 | ||
| 2017-10-04 | ADAMS THOMAS PHD Director | Grant or award · Stock Options | +38,106 | 412,955 | ||
| 2017-09-02 | ADAMS THOMAS PHD Director | Option exercise | +8,806 | 335,292 | ||
| 2017-09-02 | ADAMS THOMAS PHD Director | Option exercise · Restricted Stock Units | −8,806 | 16,667 | ||
| 2017-01-02 | ADAMS THOMAS PHD Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | ADAMS THOMAS PHD Director | Grant or award · Restricted Stock Units | +8,806 | 25,473 | ||
| 2017-01-02 | ADAMS THOMAS PHD Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 |
Page 1 of 1 · 19 trades